Sumitomo Mitsui Trust Group Inc. Buys 5,933 Shares of Elevance Health, Inc. $ELV

Key Points

• Sumitomo Mitsui Trust Group increased its stake by 5,933 shares to 949,000 shares (a 0.6% rise), now owning about 0.43% of Elevance Health worth roughly $332.67 million per its SEC filing.
• Quarterly results: Elevance reported $3.33 EPS versus $3.10 expected and revenue of $49.31 billion (slightly below consensus), with revenue up 9.6% year‑over‑year.
• Dividend and outlook: the company raised its quarterly dividend to $1.72 ($6.88 annual, ~2.2% yield), while MarketBeat shows a consensus "Hold" rating with a $385.38 target and institutional ownership of 89.24%.

Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 949,000 shares of the company's stock after acquiring an additional 5,933 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.43% of Elevance Health worth $332,672,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of ELV. Murphy Middleton Hinkle & Parker Inc. acquired a new position in shares of Elevance Health during the 4th quarter worth about $5,941,000. Evergreen Wealth Management LLC increased its stake in shares of Elevance Health by 33.5% during the 3rd quarter. Evergreen Wealth Management LLC now owns 17,283 shares of the company's stock worth $5,584,000 after purchasing an additional 4,336 shares during the last quarter. Blume Capital Management Inc. increased its stake in shares of Elevance Health by 236.7% during the 3rd quarter. Blume Capital Management Inc. now owns 6,145 shares of the company's stock worth $1,986,000 after purchasing an additional 4,320 shares during the last quarter. Canoe Financial LP increased its stake in shares of Elevance Health by 18.1% during the 3rd quarter. Canoe Financial LP now owns 389,399 shares of the company's stock worth $125,823,000 after purchasing an additional 59,743 shares during the last quarter. Finally, Synergy Asset Management LLC increased its stake in shares of Elevance Health by 100.0% during the 3rd quarter. Synergy Asset Management LLC now owns 104,334 shares of the company's stock worth $33,712,000 after purchasing an additional 52,167 shares during the last quarter. Institutional investors own 89.24% of the company's stock.

Elevance Health Stock Performance

NYSE ELV opened at $311.54 on Friday. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $68.43 billion, a P/E ratio of 12.40, a P/E/G ratio of 1.71 and a beta of 0.49. Elevance Health, Inc. has a 12-month low of $273.71 and a 12-month high of $443.29. The firm has a 50-day moving average price of $311.25 and a two-hundred day moving average price of $332.09.

Elevance Health (NYSE:ELV - Get Free Report) last posted its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.10 by $0.23. The firm had revenue of $49.31 billion during the quarter, compared to the consensus estimate of $49.52 billion. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.84 EPS. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Analysts anticipate that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 25th. Shareholders of record on Tuesday, March 10th were issued a $1.72 dividend. The ex-dividend date of this dividend was Tuesday, March 10th. This represents a $6.88 dividend on an annualized basis and a yield of 2.2%. This is an increase from Elevance Health's previous quarterly dividend of $1.71. Elevance Health's payout ratio is presently 27.39%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Barclays lowered their price objective on shares of Elevance Health from $404.00 to $393.00 and set an "overweight" rating on the stock in a research note on Friday, January 30th. Sanford C. Bernstein lowered their price objective on shares of Elevance Health from $431.00 to $409.00 and set an "outperform" rating on the stock in a research note on Friday, January 30th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $332.00 target price on shares of Elevance Health in a report on Thursday, January 29th. Evercore assumed coverage on shares of Elevance Health in a report on Wednesday. They set a "hold" rating and a $345.00 target price for the company. Finally, Morgan Stanley reduced their target price on shares of Elevance Health from $359.00 to $352.00 and set an "equal weight" rating for the company in a report on Wednesday, December 17th. Twelve research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $385.38.

Elevance Health Profile

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.